디앤디파마텍

347850KOSDAQ자연과학 및 공학 연구개발업

48.2 / 100

Reference Date: 2026-07-24

Financial Score11.0 / 40

News Sentiment18.2 / 25

Momentum7.0 / 20

Disclosure12.0 / 15

AI Analysis: the high debt ratio poses financial risk, Revenue is on a declining trend. Plunged 30.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

D&D Pharmatech is a biopharmaceutical company specializing in developing innovative drugs for metabolic diseases, such as obesity and MASH (metabolic-associated steatohepatitis), and neurodegenerative disorders like Parkinson's and Alzheimer's, leveraging GLP-1-based peptide technology. The company's key pipelines include oral weight-loss medications and MASH treatments, with a business model focused on licensing and co-development with global partners. Additionally, it expands into areas such as PET biomarker development and alpha radiation-based cancer therapies through its subsidiaries.

Number of Employees

22people

Average Salary

169.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 43.644.0Point

PBR

—Industry Average 2.523.5Point

ROE

-32.29Industry Average -32.093.5Point

In line with industry avg

Debt Ratio

16.64Industry Average 7.310.0Point

2.3x industry avg (risky)

Trend 2024~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼62.4% (1-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼35.9% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -39.8% (improving, 2yr)

Detailed News Sentiment

26 totalPositive 16Neutral 7Negative 3Average Sentiment Score 72.7

Positive
바이오 강세에 코스닥 4% 급등…매수 사이드카
바이오 섹터 강세로 코스닥이 급등하며 디앤디파마텍 포함 관련 주식들의 긍정적인 시장 분위기 형성.
Positive
살 5%도 안 빠졌는데 간 지방 37%↓…디앤디파마텍 MASH 신약 초...
디앤디파마텍의 MASH 치료제 후보물질 자보페그두타이드의 긍정적인 임상 결과가 국제 학술지 게재로 이어져 주가 상승 기대.
Positive
디앤디파마텍 "MASH 치료제 2상 초기결과, 학술지 게재"
디앤디파마텍의 MASH 치료제 후보물질 자보페그두타이드의 임상 2상 초기 결과가 국제 학술지에 게재되어 긍정적인 연구 성과를 인정받았다.

Detailed Momentum

52-week position5.0Point

52w mid range (41%)

Current 64,000Won52-week high 111,20052-week low 30,030

1-month return0.0Point

1m -30.43% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 1Neutral 0Negative 0

Positive[기재정정]단일판매ㆍ공급계약체결2026-07-14